| Name | H.e.b. Pharmacy #094 |
|---|---|
| Organization Name | H-e-b Lp |
| Location | 2409 E Expressway 83, Mission, Texas 78572 |
| Type | Supplier |
| Phone | (956) 205-6755 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will present key industry topics during the 19th Annual Partnerships in Clinical Trials Conference, to be held April 12 – 14, 2010 in Orlando, Florida.
Reuters reports that a new study has found "cancer researchers who design clinical trials, analyze or interpret the data, or play other key scientific roles are four times more likely to have financial ties to industry than their counterparts who have lesser roles in these studies, such as recruiting study subjects or collecting the data."
Researchers at Washington University School of Medicine in St. Louis have received a $9 million grant to investigate blood-clotting disorders. From heart attacks and strokes to uncontrolled bleeding, clotting disorders cause more deaths each year in the United States than all types of cancer combined.
› Verified 3 days ago
News Archive
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will present key industry topics during the 19th Annual Partnerships in Clinical Trials Conference, to be held April 12 – 14, 2010 in Orlando, Florida.
Reuters reports that a new study has found "cancer researchers who design clinical trials, analyze or interpret the data, or play other key scientific roles are four times more likely to have financial ties to industry than their counterparts who have lesser roles in these studies, such as recruiting study subjects or collecting the data."
Researchers at Washington University School of Medicine in St. Louis have received a $9 million grant to investigate blood-clotting disorders. From heart attacks and strokes to uncontrolled bleeding, clotting disorders cause more deaths each year in the United States than all types of cancer combined.
› Verified 3 days ago
Aclanza Dme Type: DME Supplier - Oxygen Equipment & Supplies Location: 900 Plaza Drive, Mission, Texas 78572 Phone: (956) 205-2981 | |
Brandon's Dme Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2716 N Conway Ave, Mission, Texas 78574 Phone: (956) 432-0153 | |
First Class Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2005 E Griffin Pkwy, Mission, Texas 78572 Phone: (956) 583-8222 | |
Cvs Pharmacy #07193 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2314 E Expwy 83, Mission, Texas 78572 Phone: (956) 585-3990 | |
Cvs Pharmacy #10107 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2300 N Conway Ave, Mission, Texas 78574 Phone: (956) 424-0591 |